Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

EXPLOGEN

Financiado

Cerrado

Exploitation of actinomycetes genomics using synthetic and system biology approa...

Exploitation of actinomycetes genomics using synthetic and system biology approaches "Actinomycetes produce a wealth of important natural products, which play a pivotal role in modern drug-based therapy of various diseases. Recent whole-genome sequencing projects have revealed that the number of biosynthetic gene... ver más

31/12/2016

HZI

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

HELMHOLTZZENTRUM FUR INFEKTIONSFORSCHUNG GMBH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2016-12-31 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

HZI

0.00€ | Lider

Proyectos interesantes

Zhou_PFL_Polyketides

Medical Technol...

Data Science

210K€ Cerrado

COMMUNITY

Medical Technol...

Biotechnology

3M€ Cerrado

RTI2018-093562-B-I00

Medical Technol...

Biotechnology

339K€ Cerrado

ACPNMR

Medical Technol...

Biotechnology

183K€ Cerrado

BIO2014-56752-R

Medical Technol...

Biotechnology

218K€ Cerrado

MeDiSyn

Medical Technol...

Biotechnology

1M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

HELMHOLTZZENTRUM FUR INFEKTIONSFORSCHUNG GMBH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 1M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "Actinomycetes produce a wealth of important natural products, which play a pivotal role in modern drug-based therapy of various diseases. Recent whole-genome sequencing projects have revealed that the number of biosynthetic gene clusters significantly outnumbers the natural products produced by actinomycetes under laboratory conditions. Only a minority of biosynthetic gene clusters are expressed under known laboratory conditions. The major challenge in the field now is to exploit this untapped reservoir of potentially active and useful compounds. Using synthetic and system biology approaches we will access these so far unavailable natural products. The overall strategy of the EXPLOGEN project will be implemented through the activities of four different work packages. WP1. Synthetic biobricks. Construction of different synthetic biobricks, which can be mixed and matched to build the synthetic devices and systems in actinomycetes. Generation of streptomyces strains with minimized genomes. WP2. Systems biology. The metabolic reconstruction of Streptomyces albus and S. lividans and its simulation in order to deliver gene targets for knockouts and overexpression experiments. Predicted mutants should accumulate main precursors of natural products, particularly polyketides. WP3. Regulatory network identification. Using systematic in vivo transposon mutagenesis combined with GFP-based flow cytometry assay and gusA based screening, we will identify gene networks responsible for the regulation and silencing of natural product biosynthesis. WP4. Metabolic engineering of the hosts. Generation of S. albus and S. lividans hosts accumulating main precursors for the heterologous production of natural products. Heterologous expression of the aranciamycin, phenalinolactone, and two ""cryptic"" biosynthetic gene clusters in the developed hosts. The outcome of this project will be a new platform for the production of novel natural products including valuable pharmaceuticals."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores